🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study is conducted to evaluate the long-term safety and tolerability of lac...
Status
Completed
Location
Sp1042 805
Start Date
2016-01
Trial ID
NCT02582866
Treatments Being Tested
The purpose of this study is to see how safe and effective Lacosamide (LCM)...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00440518
Treatments Being Tested
This is a study designed to demonstrate the Bioequivalence between Lacosami...
Status
Completed
Location
Ep0059 001
Start Date
2016-11
Trial ID
NCT02972125
Treatments Being Tested
This open-label extension trial will assess the long-term use of Lacosamide...
Status
Completed
Location
048
Start Date
2008-02
Trial ID
NCT00530855
Treatments Being Tested
The main purpose of this trial is to determine safety and efficacy of Lacos...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00515619
Treatments Being Tested
This study is to evaluate the long-term safety and tolerability of Lacosami...
Status
Completed
Location
5
Start Date
2014-04
Trial ID
NCT02124564
Treatments Being Tested
This study will be conducted to compare the pharmacokinetics of Lacosamide ...
Status
Completed
Location
001
Start Date
2013-11
Trial ID
NCT01986608
Treatments Being Tested
The purpose of this study is to assess the bioequivalence of a 200 mg singl...
Status
Completed
Location
Sp1043 001
Start Date
2017-06-08
Trial ID
NCT03204474
Treatments Being Tested
The purpose of this study is to determine if lacosamide (SPM 927) is safe i...
Status
Completed
Location
Multiple Locations
Start Date
2004-12-21
Trial ID
NCT00220337
Treatments Being Tested
The purpose of this study is to demonstrate bioequivalence between the LCM ...
Status
Completed
Location
Sp1001 001
Start Date
2017-02-27
Trial ID
NCT03086382
Treatments Being Tested